Soroprevalência do vírus da hepatite C na população em diálise de Goiânia, GO

Naghettini, Alessandra Vitorino; Daher, Renato Tavares; Martin, Regina Matsunaga; Doles, Jarbas; Vanderborght, Bart; Yoshida, Clara Fumiko Tachibana; Rouzere, C. D.

doi:10.1590/s0037-86821997000200005

Cited by 14 publications

(23 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…5 One of the risk factors for HCV transmission during hemodialysis may be dialyzer reuse, 4 a potential that was supported by the present study (Table). In the simple regression analysis, an association was found between anti-HCV seropositivity and the reuse of the dialyzer.…”

Section: Discussionsupporting

confidence: 72%

“…This can occur either through sharing of machines, environmental aerosols, droplets contaminated with the virus or during emergency situations when protective gloves are not replaces by technical teams. [2][3][4][5] Both the sharing of hemodialysis machines of nursing teams has been associated to high incidence of HCV infection. Contamination, in such cases, may be related to the methodology used in the dialysis process, such as through technical errors in biosecurity.…”

Section: Discussionmentioning

confidence: 99%

“…Contamination, in such cases, may be related to the methodology used in the dialysis process, such as through technical errors in biosecurity. [2][3][4][5] The patient may also be in an immunological window whilst sharing a room, machine or nursing team with negative patients.…”

Section: Discussionmentioning

confidence: 99%

“…[1][2][3][4][5] In conclusion, results suggest that transmissibility of HCV in dialysis centers does not occur exclusively through transfusion of contaminated blood. 4 Other factors predominate, such as longer duration of dialysis and the non-segregation of seropositive patients, which are questions of biosecurity.…”

Section: Discussionmentioning

confidence: 99%

“…1,[3][4][5] Anti-HCV exams are administered monthly in dialysis centers, as mandated by regulation n. 82/00 of the Brazilian Ministry of Health (MS). Detection of anti-HCV is undertaken through simple serology tests.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Prevalência da soropositividade do anti-HCV em pacientes dialisados

et al. 2006

View full text Add to dashboard Cite

This cross-sectional study evaluated the prevalence of anti-hepatitis antibodies and associated factors in dialysis patients. Data were collected from records of all patients receiving dialysis treatment [n=1,261] in the city of Porto Alegre, in Southern Brazil, from August to December 2003. The statistical analyses used were Chi-square and the linear tendency test. Prevalence ratios were also calculated. Multiple logistic regression analysis was performed through Cox regression. The prevalence of antihepatitis antibodies was of 29.1%, and was higher among patients treated by hemodialysis where there was no segregation of seropositive and seronegative patients and where dialyzers were reused. This association remained even when controlling for confounding factors. Patients who received blood transfusions had a linear increase in the prevalence of anti-hepatitis antibodies. The duration of dialysis treatment showed a dose-response curve with the prevalence of anti-hepatitis antibodies.

show abstract

Section: Discussionsupporting

confidence: 72%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Prevalência da soropositividade do anti-HCV em pacientes dialisados

et al. 2006

View full text Add to dashboard Cite

show abstract

Caracterização sorológica e molecular da infecção pelo vírus da hepatite C (HCV) em doadores de sangue do Estado do Amazonas

Silva¹

View full text Add to dashboard Cite

, agradeço pela verdadeira acolhida e pelo suporte sempre dispensado. À Secretaria do Programa de Pós-graduação em Doenças Infecciosas e parasitárias pelo suporte oferecido. À Fundação de Hematologia e Hemoterapia do Amazonas-HEMOAM pelo suporte e incentivo a realização deste estudo. À Dra. Leny Nascimento da Motta Passos Diretora Presidente da Fundação de Hematologia e Hemoterapia do Amazonas-HEMOAM pela oportunidade e confiança. A equipe técnica do Laboratório de Sorologia da Fundação HEMOAM em nome da Dra. Márcia Poinho Encarnação de Moraes, pela amizade, pelo apoio e suporte técnico dispensados. À Dra. Adriana Malheiro, pela co-orientação, incentivo e suporte técnico dispensados.

show abstract